235 related articles for article (PubMed ID: 28956156)
61. Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.
Tamrazi B; Liu CJ; Cen SY; Nelson MB; Dhall G; Nelson MD
Radiology; 2018 Oct; 289(1):188-194. PubMed ID: 29989524
[TBL] [Abstract][Full Text] [Related]
62. Dentate nucleus T1 hyperintensity: is it always gadolinium all that glitters?
Pasquini L; Rossi Espagnet MC; Napolitano A; Longo D; Bertaina A; Visconti E; Tomà P
Radiol Med; 2018 Jun; 123(6):469-473. PubMed ID: 29374857
[TBL] [Abstract][Full Text] [Related]
63. Gadolinium Deposition in the Brain: A Systematic Review of Existing Guidelines and Policy Statement Issued by the Canadian Association of Radiologists.
Costa AF; van der Pol CB; Maralani PJ; McInnes MDF; Shewchuk JR; Verma R; Hurrell C; Schieda N
Can Assoc Radiol J; 2018 Nov; 69(4):373-382. PubMed ID: 30249408
[TBL] [Abstract][Full Text] [Related]
64. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
[TBL] [Abstract][Full Text] [Related]
65. Gadolinium contrast agents - are they really safe?
Malikova H; Holesta M
J Vasc Access; 2017 Mar; 18(Suppl. 2):1-7. PubMed ID: 28362042
[TBL] [Abstract][Full Text] [Related]
66. The Effect of Perinatal Gadolinium-Based Contrast Agents on Adult Mice Behavior.
Khairinisa MA; Takatsuru Y; Amano I; Erdene K; Nakajima T; Kameo S; Koyama H; Tsushima Y; Koibuchi N
Invest Radiol; 2018 Feb; 53(2):110-118. PubMed ID: 28915162
[TBL] [Abstract][Full Text] [Related]
67. Adverse Reactions to Gadoterate Meglumine: Review of Over 25 Years of Clinical Use and More Than 50 Million Doses.
de Kerviler E; Maravilla K; Meder JF; Naggara O; Dubourdieu C; Jullien V; Desché P
Invest Radiol; 2016 Sep; 51(9):544-51. PubMed ID: 27504794
[TBL] [Abstract][Full Text] [Related]
68. Gadolinium-based contrast agents for imaging of the central nervous system: A multicenter European prospective study.
Heshmatzadeh Behzadi A; McDonald J
Medicine (Baltimore); 2022 Aug; 101(34):e30163. PubMed ID: 36042629
[TBL] [Abstract][Full Text] [Related]
69. Empiric Switching of Gadolinium-Based Contrast Agents in Patients With History of Previous Immediate Hypersensitivity Reaction to GBCA: A Prospective Single-Center, Single-Arm Efficacy Trial.
Walker D; McGrath TA; Glikstein R; Chakraborty S; Blanchette C; Schieda N
Invest Radiol; 2021 Jun; 56(6):369-373. PubMed ID: 33337738
[TBL] [Abstract][Full Text] [Related]
70. Use of Real-Life Safety Data From International Pharmacovigilance Databases to Assess the Importance of Symptoms Associated With Gadolinium Exposure.
Shahid I; Joseph A; Lancelot E
Invest Radiol; 2022 Oct; 57(10):664-673. PubMed ID: 35471204
[TBL] [Abstract][Full Text] [Related]
71. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
[TBL] [Abstract][Full Text] [Related]
72. Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI.
Khouri Chalouhi K; Papini GDE; Bandirali M; Sconfienza LM; Di Leo G; Sardanelli F
Eur J Radiol; 2014 Jul; 83(7):1245-1249. PubMed ID: 24816087
[TBL] [Abstract][Full Text] [Related]
73. Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Anzalone N; Scarabino T; Venturi C; Cristaudo C; Tartaro A; Scotti G; Zimatore D; Floris R; Carriero A; Longo M; Cirillo M; Cova MA; Gatti S; Voth M; Colosimo C
Eur J Radiol; 2013 Jan; 82(1):139-45. PubMed ID: 21890295
[TBL] [Abstract][Full Text] [Related]
74. Safety of gadoterate meglumine in children younger than 2 years of age.
Farmakis SG; Hardy AK; Mahmoud SY; Wilson-Flewelling SA; Tao TY
Pediatr Radiol; 2020 May; 50(6):855-862. PubMed ID: 32055917
[TBL] [Abstract][Full Text] [Related]
75. Gadolinium deposition in the brain.
Kanda T; Nakai Y; Oba H; Toyoda K; Kitajima K; Furui S
Magn Reson Imaging; 2016 Dec; 34(10):1346-1350. PubMed ID: 27613998
[TBL] [Abstract][Full Text] [Related]
76. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
[TBL] [Abstract][Full Text] [Related]
77. Development of high signal intensity within the globus pallidus and dentate nucleus following multiple administrations of gadoterate meglumine in a patient with neurotuberculosis.
Cankaya B; Ogul Y; Ogul H; Kantarci M
Acta Neurol Belg; 2022 Jun; 122(3):781-784. PubMed ID: 33393069
[No Abstract] [Full Text] [Related]
78. Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis.
Nakamura K; McGinley MP; Jones SE; Lowe MJ; Cohen JA; Ruggieri PM; Ontaneda D
J Neuroimaging; 2023 Jan; 33(1):85-93. PubMed ID: 36181666
[TBL] [Abstract][Full Text] [Related]
79. Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?
Bonafè R; Coppo A; Queliti R; Bussi S; Maisano F; Kirchin MA; Tedoldi F
Eur Radiol Exp; 2023 Mar; 7(1):7. PubMed ID: 36855001
[TBL] [Abstract][Full Text] [Related]
80. Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls, while the neuropil is not affected: an autopsy study.
Fingerhut S; Sperling M; Holling M; Niederstadt T; Allkemper T; Radbruch A; Heindel W; Paulus W; Jeibmann A; Karst U
Acta Neuropathol; 2018 Jul; 136(1):127-138. PubMed ID: 29748901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
